Relaxivity properties of magnetoferritin: The iron loading effect.

Contrast agent Iron oxide nanoparticles Magnetic resonance imaging Magnetoferritin Relaxivity

Journal

Journal of bioscience and bioengineering
ISSN: 1347-4421
Titre abrégé: J Biosci Bioeng
Pays: Japan
ID NLM: 100888800

Informations de publication

Date de publication:
May 2022
Historique:
received: 07 09 2021
revised: 11 01 2022
accepted: 11 01 2022
pubmed: 13 3 2022
medline: 14 4 2022
entrez: 12 3 2022
Statut: ppublish

Résumé

Self-assembling ferritin protein cages have been used as a template for magnetic iron oxide nanoparticle synthesis within its 8 nm cavity to be explored as a potential magnetic resonance imaging contrast agent. Here in, magnetic nanocores with various iron content were successfully synthesized using recombinant human H-chain ferritin (HFn) by a controlled mineralization reaction. r1 and r2 relaxivities of the synthesized magnetoferritin nanoparticles were measured and the effect of iron loading factor on the r1 and r2 relaxivity was investigated by using a quite large range of 10 different iron loadings per protein cage (500-5000) at 90 MHz and 300 MHz. The sample with the highest iron loading of 5329 Fe/cage has r2 value of 165.2 mM

Identifiants

pubmed: 35277341
pii: S1389-1723(22)00005-6
doi: 10.1016/j.jbiosc.2022.01.005
pii:
doi:

Substances chimiques

Contrast Media 0
Oxides 0
magnetoferritin 0
Ferritins 9007-73-2
Apoferritins 9013-31-4
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

474-480

Informations de copyright

Copyright © 2022 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Auteurs

Tuğba Nur Aslan (TN)

Department of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA; Department of Chemistry, Middle East Technical University, Ankara 06800, Turkey. Electronic address: taslan@erbakan.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH